Publications by authors named "Hunter D Reavis"

Claim this Profile
N
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells.
Hunter D Reavis, Stefan M Gysler, Grace B McKenney, Matthew Knarr, Hannah J Lusk

JCI Insight· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary.
Kai Doberstein, Rebecca Spivak, Hunter D Reavis, Jagmohan Hooda, Yi Feng

Commun Biol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity.
Timothy B Branigan, David Kozono, Amy E Schade, Peter Deraska, Hembly G Rivas, Hunter D Reavis

Cell Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Innervation: Cancer Has Some Nerve.
Hunter D Reavis, H Isaac Chen, Ronny Drapkin

Trends Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tubal epigenome - An emerging target for ovarian cancer.
Hunter D Reavis, Ronny Drapkin

Pharmacol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition.
Kalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, Zhigang C Wang, Sangeetha Palakurthi, Hunter D Reavis

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair.
Peter V Deraska, Colin O'Leary, Hunter D Reavis, Shelby Labe, Tru-Khang Dinh

Cell Death Discov· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative, Point-of-Care Immunoassay Platform to Guide and Monitor Sickle Cell Disease Therapy.
Xiaoxi Yang, Hunter D Reavis, Christopher L Roberts, Jason S Kim

Anal Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis